Detalhe da pesquisa
1.
Oestrogens and overactive bladder.
Neurourol Urodyn
; 33(7): 1086-91, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23868110
2.
[Spanish validation of the Epidemiology of Prolapse and Incontinence Questionnaire-EPIQ]. / Validación de la versión en español del cuestionario "Epidemiology of Prolapse and Incontinence Questionnaire-EPIQ".
Actas Urol Esp
; 33(6): 646-53, 2009 Jun.
Artigo
em Espanhol
| MEDLINE | ID: mdl-19711748
3.
A review of adherence to drug therapy in patients with overactive bladder.
BJU Int
; 102(7): 774-9, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18616691
4.
Medical resource utilisation and cost of care for women seeking treatment for urinary incontinence in an outpatient setting. Examples from three countries participating in the PURE study.
Maturitas
; 52 Suppl 2: S35-47, 2005 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-16297577
5.
A description of health care provision and access to treatment for women with urinary incontinence in Europe -- a five-country comparison.
Maturitas
; 52 Suppl 2: S3-12, 2005 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-16297578
6.
Patient-reported impact of urinary incontinence--results from treatment seeking women in 14 European countries.
Maturitas
; 52 Suppl 2: S24-34, 2005 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-16297579
7.
Characteristics of female outpatients with urinary incontinence participating in a 6-month observational study in 14 European countries.
Maturitas
; 52 Suppl 2: S13-23, 2005 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-16297580
8.
Stress incontinence injection therapy: what is best for our patients?
Eur Urol
; 48(4): 552-65, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16118034